Germany's industrial giants pivot to arms as China's carmakers close in
The same forces that made German automakers dominant now push their suppliers toward defense contracts. Here is what the shift means for the industry.

Loading the Newsroom
Curating from trusted global sources…
6 briefings · “trial”
The same forces that made German automakers dominant now push their suppliers toward defense contracts. Here is what the shift means for the industry.
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.
All-cash acquisition delivers divesiran, a late-stage-ready experimental treatment, to Merck KGaA's pipeline.
Bangkok's open-door policy for Chinese electric vehicles is now forcing a painful recalibration as local manufacturing faces an existential threat.
David Ellison's studio avoids a March trial and a $7M-a-day ticking fee by settling with state AGs over local job losses.
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.